Concepedia

Cécile Pautas

CP

Statistics

Publications

73

Citations

6.4K

H-Index

40

Active since

2000

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Hôpital Saint-Louis

Université Paris Cité

Hôpitaux Universitaires Henri-Mondor

Inserm

Cécile Pautas is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, oncology, and acute myeloid leukemia therapy.

Publications per year

2000–2025

73

Publications

73

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Sylvie Castaigné, Cécile Pautas, Christine Terré et al. · The Lancet · 2012 · 995 citations

Medicine, Hematology, Pharmacology +10

Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial

Catherine Cordonnier, Cécile Pautas, Sébastien Maury et al. · Clinical Infectious Diseases · 2009 · 387 citations

Pharmacy, Infectious Diseases, Oncology +17

Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia

Éric Jourdan, Nicolas Boissel, Sylvie Chevret et al. · Blood · 2013 · 357 citations

Medicine, Hematology, Oncology +16

Gemtuzumab ozogamicin for <i>de novo</i> acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial

Juliette Lambert, Cécile Pautas, Christine Terré et al. · Haematologica · 2018 · 352 citations · Full text

Medicine, Oncology, Pharmacology +15

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

A.-L. Taksin, Ollivier Legrand, Emmanuel Raffoux et al. · Leukemia · 2006 · 288 citations

Medicine, Oncology, Pharmacology +10

1–5 of 73